Related Experiment Video
Updated: Jan 20, 2026

Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease
Published on: April 28, 2023
Abstract:
The FDA recently approved fedratinib for myelofibrosis, making it just the second drug approved for the disease, as well as the second approved JAK inhibitor. The approval was based on the phase III JAKARTA trial, in which the drug significantly reduced symptoms compared with a placebo. However, the drug comes with a Boxed Warning for encephalopathy.
Related Concept Videos
04:11Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease
10:15Streamlined 3D Cerebellar Differentiation Protocol with Optional 2D Modification
06:12Plasma Polishing as a New Polishing Option to Reduce the Surface Roughness of Porous Titanium Alloy for 3D Printing
07:20Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium
08:46Genetic Variant Detection in the CALR gene using High Resolution Melting Analysis
An Introduction to the Micropipettor

